DABIGATRAN IN ATRIAL FIBRILLATION: DOSE TITRATION USING THROMBIN TIME

被引：0
|
作者：
Wright, Richard F. [1 ,2 ]
机构：
[1] Pacific Heart Inst, Santa Monica, CA USA
[2] Providence St Johns Hlth Ctr, Santa Monica, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(16)30881-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1268-347
引用
收藏
页码：880 / 880
页数：1
相关论文
共 50 条
  • [1] A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
    Chin, Paul K. L.
    Wright, Daniel F. B.
    Patterson, David M.
    Doogue, Matthew P.
    Begg, Evan J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (03) : 599 - 609
  • [2] Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation
    Bendel, Stephen D.
    Bona, Robert
    Baker, William L.
    ADVANCES IN THERAPY, 2011, 28 (06) : 460 - 472
  • [3] Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation
    Stephen D. Bendel
    Robert Bona
    William L. Baker
    Advances in Therapy, 2011, 28 : 460 - 472
  • [4] Monitoring of dabigatran therapy using Hemoclot® Thrombin Inhibitor assay in patients with atrial fibrillation
    Matej Samoš
    Lucia Stančiaková
    Jela Ivanková
    Ján Staško
    František Kovář
    Miroslava Dobrotová
    Peter Galajda
    Peter Kubisz
    Marián Mokáň
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 95 - 100
  • [5] Monitoring of dabigatran therapy using Hemoclot® Thrombin Inhibitor assay in patients with atrial fibrillation
    Samos, Matej
    Stanciakova, Lucia
    Ivankova, Jela
    Stasko, Jan
    Kovar, Frantisek
    Dobrotova, Miroslava
    Galajda, Peter
    Kubisz, Peter
    Mokan, Marian
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (01) : 95 - 100
  • [6] Safety and efficacy of a new oral direct thrombin inhibitor Dabigatran in atrial fibrillation - a dose finding trial with comparison to Warfarin
    Wallentin, L. C.
    Ezekowitz, M.
    Simmers, T. A.
    Pedersen, K. E.
    Stangier, J.
    Nehmiz, G.
    Reilly, P.
    EUROPEAN HEART JOURNAL, 2005, 26 : 482 - 483
  • [7] Cardioversion of atrial fibrillation using dabigatran as thromboembolic prophylaxis
    Johansson, A. -K.
    Juhlin, T.
    Hagwall, K.
    Engdahl, J.
    Rorsman, C.
    Rosenqvist, M.
    Frick, M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1100 - 1100
  • [8] Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation
    Achilles, A.
    Mohring, A.
    Dannenberg, L.
    Grandoch, M.
    Hohlfeld, T.
    Fischer, J. W.
    Levkau, B.
    Kelm, M.
    Zeus, T.
    Polzin, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (03) : 473 - 476
  • [9] Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation
    Piayda, K.
    Mohring, A.
    Dannenberg, L.
    Achilles, A.
    Grandoch, M.
    Hohlfeld, T.
    Fischer, J.
    Levkau, B.
    Kelm, M.
    Zeus, T.
    Polzin, A.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1133 - 1133
  • [10] Cost of dabigatran for atrial fibrillation
    Gage, Brian F.
    BRITISH MEDICAL JOURNAL, 2011, 343
12345